- Investing Ideas
- /
- Norwegian Biotech Stocks
Norwegian Biotech Stocks
Results
12
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
12 companies
Photocure
Market Cap: NOK 1.6b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 61.90
7D
0.3%
1Y
27.6%
ArcticZymes Technologies
Market Cap: NOK 1.4b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 26.50
7D
34.9%
1Y
12.8%
Vistin Pharma
Market Cap: NOK 1.1b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 24.40
7D
-0.4%
1Y
10.9%
Hofseth BioCare
Market Cap: NOK 717.3m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.75
7D
-1.7%
1Y
-16.9%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
1.1%
1Y
n/a
Navamedic
Market Cap: NOK 415.1m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 23.50
7D
-8.9%
1Y
-24.9%
SoftOx Solutions
Market Cap: NOK 294.3m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.13
7D
30.5%
1Y
275.0%
Zelluna
Market Cap: NOK 278.2m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 13.60
7D
-1.1%
1Y
n/a
EXACT Therapeutics
Market Cap: NOK 184.7m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 2.92
7D
5.8%
1Y
-58.3%
Arctic Bioscience
Market Cap: NOK 88.4m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.29
7D
-9.9%
1Y
-75.4%
PCI Biotech Holding
Market Cap: NOK 55.8m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 1.50
7D
0%
1Y
-13.4%
BerGenBio
Market Cap: NOK 44.9m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.15
7D
-3.4%
1Y
-90.2%